Furthermore, Dichloroacetate, which can restore mitochondrial function, has proven its effectiveness in experimental models of cancer and PAH through the enhancement of glucose oxidation (GO) and the attenuation of mitochondria-induced hypoxia-inducible factor 1α (HIF-1α) signaling [5]. Here, HIF1A is linked to pulmonary arterial hypertension.